Abilify’s Adherence Sensor: Thoughts to Consider in the Regulatory Process

By Anikka Hoidal for BiolawToday.org. Abilify is a medication frequently used to treat schizophrenia and bipolar disorder. Japan-based Otsuka Pharmaceutical Company developed the drug. Otsuka has teamed up with Proteus Health to use its sensor technology, which can provide notification that a pill has been ingested. The sensor works in combination with a patch patients wear […]